Author Correction: PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma

Affiliations

• ¹ Department of Surgery, Graduate School of Medicine, Kyoto University, 54, Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
• ² Department of Surgery, Graduate School of Medicine, Kyoto University, 54, Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. [email protected].
• ³ Department of Surgery, Ijinkai Takeda General Hospital, 28-1, Ishida Moriminami-cho, Fushimi-ku, Kyoto, 601-1495, Japan.
• ⁴ Department of Gastroenterological Surgery, New Tokyo Hospital, 1271, Wanagaya, Matsudo, Chiba, 270-2232, Japan.
• ⁵ Department of Surgery, Osaka Red Cross Hospital, 5-30, Fudegasaki-cho, Tennoji-ku, Osaka, 543-8555, Japan.
• ⁶ Department of Surgery, Kyoto Katsura Hospital, 17, Yamada-Hirao-cho, Nishikyo-ku, Kyoto, 615-8256, Japan.
• ⁷ Department of Gastrointestinal Surgery, Tenri Hospital, 200, Mishima-cho, Tenri, Nara, 632-8552, Japan.
• ⁸ Department of Surgery, National Hospital Organization Kyoto Medical Center, 1-1, Fukakusa-Mukaihata-cho, Fushimi-ku, Kyoto, 612-8555, Japan.
• ⁹ Department of Diagnostic Pathology, Graduate School of Medicine, Kyoto University, 54, Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.